Table of Content




1. Executive Summary


2. Global RNAi Drug Delivery Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global RNAi Drug Delivery Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global RNAi Drug Delivery Market by Technology
3.3.1: Nanoparticle Drug Delivery
3.3.2: Pulmonary Drug Delivery
3.3.3: Nucleic Acid Drug Delivery
3.3.4: Aptamer Drug Delivery


3.4: Global RNAi Drug Delivery Market by Application
3.4.1: Infectious Disease
3.4.2: Cardiology
3.4.3: Oncology
3.4.4: Neurology
3.4.5: Ophthalmology
3.4.6: Urology
3.4.7: Metabolic Disorders
3.4.8: Others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global RNAi Drug Delivery Market by Region
4.2: North American RNAi Drug Delivery Market
4.2.1: North American RNAi Drug Delivery Market by Technology: Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, and Aptamer Drug Delivery
4.2.2: North American RNAi Drug Delivery Market by Application: Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others


4.3: European RNAi Drug Delivery Market
4.3.1: European RNAi Drug Delivery Market by Technology: Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, and Aptamer Drug Delivery
4.3.2: European RNAi Drug Delivery Market by Application: Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others


4.4: APAC RNAi Drug Delivery Market
4.4.1: APAC RNAi Drug Delivery Market by Technology: Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, and Aptamer Drug Delivery
4.4.2: APAC RNAi Drug Delivery Market by Application: Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others


4.5: ROW RNAi Drug Delivery Market
4.5.1: ROW RNAi Drug Delivery Market by Technology: Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, and Aptamer Drug Delivery
4.5.2: ROW RNAi Drug Delivery Market by Application: Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global RNAi Drug Delivery Market by Technology
6.1.2: Growth Opportunities for the Global RNAi Drug Delivery Market by Application
6.1.3: Growth Opportunities for the Global RNAi Drug Delivery Market by Region

6.2: Emerging Trends in the Global RNAi Drug Delivery Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global RNAi Drug Delivery Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global RNAi Drug Delivery Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Alnylam Pharmaceuticals
7.2: Arrowhead Pharmaceuticals
7.3: CureVac
7.4: Dicerna Pharmaceuticals
7.5: Gradalis
7.6: Ionis Pharmaceuticals
7.7: Merck
7.8: Moderna
7.9: Quark Pharmaceuticals
7.10: Silence Therapeutics